Renal Amyloidosis
Learn what the condition is, how it may be detected early, how it is treated or managed, and which breeds or species are linked to it.
Condition snapshot
A concise guide to the condition’s pattern, detection, management and urgency.
This snapshot is a general guide, not a diagnosis or treatment plan. New, severe or worsening signs require veterinary assessment.
About the condition
Renal amyloidosis is a disorder in which abnormal protein called amyloid accumulates within the kidneys and damages their normal structure. The deposits interfere with filtration and can lead to protein loss into the urine, chronic kidney disease and, in severe cases, kidney failure. Certain family lines, particularly in Abyssinian and related cats, have recognised inherited susceptibility, although amyloidosis can also occur without a known breed association.
Some affected cats develop marked proteinuria before kidney values rise. Others present with increased thirst and urination, weight loss, poor appetite, vomiting or dehydration as kidney function declines.
Protein loss can contribute to low blood protein, fluid accumulation or an increased risk of abnormal blood clotting. High blood pressure may also occur. The age of onset and rate of progression vary considerably between cats and family lines.
Renal amyloidosis is progressive and there is no treatment that removes established amyloid deposits reliably. Care therefore focuses on preserving kidney function, reducing complications from protein loss and maintaining hydration, appetite and body condition for as long as possible.
The disorder may also affect tissues outside the kidneys in some cats, depending on the form of amyloidosis. However, renal involvement is particularly important because heavy urinary protein loss and progressive loss of filtration can develop before an owner notices dramatic illness. Trends in urine protein and kidney function therefore deserve close attention.
Substantial urinary protein loss may precede obvious kidney failure and contributes to declining body condition, clotting risk and progressive renal injury. Protein loss from glomerular disease differs from protein associated with lower urinary inflammation or infection, even when both appear in urine. Early detection is valuable because protein loss, hypertension and CKD complications can be managed before severe deterioration develops.
Screening & Early Detection
Cats from lines with a history of renal amyloidosis benefit from careful family-history review and routine kidney monitoring. There is no universally applicable DNA screening test for all feline renal amyloidosis, so a normal genetic panel does not exclude the disorder.
Regular health checks should include body weight, blood pressure, blood chemistry and urinalysis.
At home, increased thirst, larger urine clumps, weight loss, reduced appetite, vomiting or loss of muscle should trigger investigation. Ultrasound may be useful when kidney architecture needs assessment, although imaging alone cannot prove that amyloid is present.
A definitive diagnosis may require biopsy, but the decision depends on how likely the result is to change treatment and whether the cat is stable enough for the procedure.
Amyloid may accumulate in the glomeruli, the microscopic filters of the kidney, allowing large amounts of protein to escape into urine. Diagnosis begins with blood tests, urinalysis and measurement of the urine protein-to-creatinine ratio. Blood pressure is important, and ultrasound can assess kidney size and architecture. Definitive confirmation of amyloid deposits requires tissue examination, but kidney biopsy is not appropriate for every cat because it carries risk and may not change management.
Treatment & Management
Treatment is supportive because established amyloid deposits cannot usually be removed. Management is based on the stage of kidney disease and the amount of protein being lost in urine. A therapeutic renal diet may be recommended once chronic kidney disease is present, together with measures to maintain hydration and calorie intake.
Cats with significant proteinuria may receive medication aimed at reducing pressure within the kidney’s filtering units and limiting further protein loss. Blood pressure is monitored and treated if high. Phosphorus, potassium, nausea, poor appetite and anaemia are managed as needed, following the same principles used in chronic kidney disease.
Marked protein loss can alter clotting risk, so the veterinarian may consider antithrombotic treatment in selected cats. Fluid therapy must be individualised, particularly when blood protein is low or concurrent heart disease is present.
Regular monitoring is essential because progression can be unpredictable. Body weight, muscle condition, blood pressure, kidney values and urine protein are reassessed to judge response and adjust treatment. Breeding cats from strongly affected family lines should be selected conservatively, because inherited susceptibility can be difficult to predict. For pet cats, management is centred on comfort, hydration, nutrition and controlling complications for as long as good quality of life can be maintained.
Breeds or species affected
Abyssinian
Open cat breed description, care requirements and conditions
Colorpoint Shorthair
Open cat breed description, care requirements and conditions
Oriental Longhair
Open cat breed description, care requirements and conditions
Oriental Shorthair
Open cat breed description, care requirements and conditions
Siamese
Open cat breed description, care requirements and conditions
Somali
Open cat breed description, care requirements and conditions
Thai
Open cat breed description, care requirements and conditions